Commentary: What is the optimal PPI dosing following endoscopic haemostasis in acute ulcer bleeding? Authors' reply

CHIEN-CHUAN CHENHSIU-PO WANGMING-SHIANG WU2021-01-152021-01-1520120269-2813https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860538924&doi=10.1111%2fj.1365-2036.2012.05095.x&partnerID=40&md5=1e53df4fbd4a8324389ec0cc971da609https://scholars.lib.ntu.edu.tw/handle/123456789/541021[SDGs]SDG3cytochrome P450 2C19; hemoglobin; proton pump inhibitor; blood pressure; clinical effectiveness; cost effectiveness analysis; disease association; drug dose comparison; drug megadose; gastroscopy; heart rate; Helicobacter infection; hemoglobin blood level; hemostasis; human; note; optimal drug dose; peptic ulcer bleeding; prevalence; priority journal; protein polymorphism; recurrent disease; risk factor; surgical technique; treatment outcomeCommentary: What is the optimal PPI dosing following endoscopic haemostasis in acute ulcer bleeding? Authors' replynote10.1111/j.1365-2036.2012.05095.x2-s2.0-84860538924